Schedule 13G ownership disclosure

AGEX THERAPEUTICS INC

Security class unavailable · CUSIP: 00848H108

Event date: 2019-03-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,711,746
Percent of class
7.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897101-19-000289
Form type
SC 13G/A
Filer
Serina Therapeutics, Inc.
CIK
CIK 1708599
Filed
Mar 26, 2019
Reporting period
Mar 18, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub